1 / 3

Next-Generation Sequencing (NGS) Market-converted

Improving reimbursement scenarios for NGS technology in various countries is likely to lead to higher adoption of NGS technology and thereby is expected to boost the growth of the market.

Rachana1
Download Presentation

Next-Generation Sequencing (NGS) Market-converted

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Next-Generation Sequencing (NGS) Market: Understanding the Key Product Segments and Their Future during 2021-2031 Next-Generation Sequencing (NGS) Market by Products & Services [Systems & Instruments, Consumables, and Software & Service], Technology [Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, and Nanopore Sequencing], Application [Diagnostics, and Drug Discovery & Development], End User [Hospitals and Clinical & Pathology Labs] – Global Outlook & Forecast 2021-2031 According to the deep-dive market assessment study conducted by Growth+Reports, the global next-generation sequencing (NGS) market was pegged at ~US$ 9.4 billion in 2020. The market is expected to witness a CAGR of ~20.5% from 2021 to 2031. Improving reimbursement scenarios for NGS technology in various countries is likely to lead to higher adoption of NGS technology and thereby is expected to boost the growth of the market. For instance, in Jan 2020, the Centres for Medicare & Medicaid Services (CMS) announced to cover FDA approved or cleared laboratory diagnostic tests using next- generation sequencing (NGS) for patients with germline (inherited) ovarian or breast cancer. In an effort to maintain their position in the market, prominent players are continuously launching several novel and technologically advanced systems that can be used for a broader range of applications and offer more advantages. For instance, in July 2020, Thermo Fisher Scientific and First Genetics JCS announced a strategic partnership focused on commercializing next-generation sequencing (NGS)–based diagnostics in Russia. To access the Sample PDF of this research study, please request here: https://growthplusreports.com/inquiry/request-sample/next-generation-sequencing-(ngs)- market/7680 The report includes an in-depth study of the global market Next-Generation Sequencing (NGS), where segments and sub-segments are analysed in quite a detail. This research will help players focus on high-growth segments and modify their business strategies if needed. The Diabetes Care Devices global market is segmented based on Products, Technology, and End Users. The regional segmentation research presented in the report provides players with valuable insights and data regarding key geographic markets such as North America, Europe, Asia Pacific, and the Rest of the World (RoW). Our researchers and analysts use reliable primary and secondary sources for research and data. Some of the prominent players operating in the Next-Generation Sequencing (NGS) market includes: - •Illumina, Inc •Thermo Fisher Scientific •PerkinElmer Inc •QIAGEN •Eurofins Scientific •F. Hoffmann-La Roche Ltd •Takara Bio Inc •GENEWIZ •BGI •Macrogen Oceania

  2. Table of Contents 1. INTRODUCTION 1. Market Ecosystem 2. Geographic Scope 3. Timeline Under Consideration 1. Historical Years – 2018 & 2019 2. Base Year – 2020 3. Forecasted Years – 2021 to 2031 4. Currency Used in the Report 2. RESEARCH METHODOLOGY 1. Research Approach 2. Data Collection Methodology 3. Data Sources 1. Secondary Sources 2. Primary Sources 4. Market Estimation Approach 1. Bottom Up 2. Top Down 5. Market Forecasting Model 6. Limitations and Assumptions 3. PREMIUM INSIGHTS 1. Current Market Trend (COVID-19 Perspective) 2. Technological Advancements 3. Key Players & Their Competitive Positioning (2020) 4. MARKET DYNAMICS 1. Drivers 2. Restraints/Challenges 3. Opportunities 5. GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET – ANALYSIS & FORECAST, BY PRODUCT & SERVICES 1. Systems & Instruments 2. Consumables 3. Software & Services 6. GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET – ANALYSIS & FORECAST, BY TECHNOLOGY 1. Sequencing by Synthesis 2. Ion Semiconductor Sequencing 3. Single-molecule Real-time Sequencing 4. Nanopore Sequencing 5. Other Sequencing Technologies (Sequencing by Ligation, Pyrosequencing, Etc.) 7. GLOBAL NEXT-GENERATION SEQUENCING (NGS) MARKET – ANALYSIS & FORECAST, BY APPLICATION 1. Diagnostics 2. Drug Discovery & Development

  3. 3. Others Application (Personalized Medicine, Forensic, Etc.) TOC Continued… Browse the full report now: https://growthplusreports.com/report/next-generation-sequencing- (ngs)-market/7680 About Us: Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

More Related